Skip to main content
NCBI home page
British Heart Journal logoLink to British Heart Journal
. 1992 Apr;67(4):281–284. doi: 10.1136/hrt.67.4.281

Antiphospholipid antibodies and cardiovascular disease.

H L Beynon 1, M J Walport 1
PMCID: PMC1024832  PMID: 1389700

Full text

PDF
281

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Asherson R. A., Chan J. K., Harris E. N., Gharavi A. E., Hughes G. R. Anticardiolipin antibody, recurrent thrombosis, and warfarin withdrawal. Ann Rheum Dis. 1985 Dec;44(12):823–825. doi: 10.1136/ard.44.12.823. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Asherson R. A., Higenbottam T. W., Dinh Xuan A. T., Khamashta M. A., Hughes G. R. Pulmonary hypertension in a lupus clinic: experience with twenty-four patients. J Rheumatol. 1990 Oct;17(10):1292–1298. [PubMed] [Google Scholar]
  3. Asherson R. A., Khamashta M. A., Baguley E., Oakley C. M., Rowell N. R., Hughes G. R. Myocardial infarction and antiphospholipid antibodies in SLE and related disorders. Q J Med. 1989 Dec;73(272):1103–1115. [PubMed] [Google Scholar]
  4. Asherson R. A., Khamashta M. A., Ordi-Ros J., Derksen R. H., Machin S. J., Barquinero J., Outt H. H., Harris E. N., Vilardell-Torres M., Hughes G. R. The "primary" antiphospholipid syndrome: major clinical and serological features. Medicine (Baltimore) 1989 Nov;68(6):366–374. [PubMed] [Google Scholar]
  5. Asherson R. A., Mercey D., Phillips G., Sheehan N., Gharavi A. E., Harris E. N., Hughes G. R. Recurrent stroke and multi-infarct dementia in systemic lupus erythematosus: association with antiphospholipid antibodies. Ann Rheum Dis. 1987 Aug;46(8):605–611. doi: 10.1136/ard.46.8.605. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Asherson R. A., Oakley C. M. Pulmonary hypertension and systemic lupus erythematosus. J Rheumatol. 1986 Feb;13(1):1–5. [PubMed] [Google Scholar]
  7. Chartash E. K., Lans D. M., Paget S. A., Qamar T., Lockshin M. D. Aortic insufficiency and mitral regurgitation in patients with systemic lupus erythematosus and the antiphospholipid syndrome. Am J Med. 1989 Apr;86(4):407–412. doi: 10.1016/0002-9343(89)90337-9. [DOI] [PubMed] [Google Scholar]
  8. De Caterina R., d'Ascanio A., Mazzone A., Gazzetti P., Bernini W., Neri R., Bombardieri S. Prevalence of anticardiolipin antibodies in coronary artery disease. Am J Cardiol. 1990 Apr 1;65(13):922–923. doi: 10.1016/0002-9149(90)91439-d. [DOI] [PubMed] [Google Scholar]
  9. Eber B., Kronberger-Schaffer E., Brussee H., Klima G., Obernosterer A., Toporsch M., Dusleag J., Klein W. Anticardiolipin antibodies are no marker for survived myocardial infarction. Klin Wochenschr. 1990 Jun 19;68(12):594–596. doi: 10.1007/BF01660956. [DOI] [PubMed] [Google Scholar]
  10. Englert H., Derue G., Hughes G. R. Neurology and the lupus anticoagulant. Eur Neurol. 1985;24(6):422–425. doi: 10.1159/000115836. [DOI] [PubMed] [Google Scholar]
  11. Fauci A. S., Haynes B., Katz P. The spectrum of vasculitis: clinical, pathologic, immunologic and therapeutic considerations. Ann Intern Med. 1978 Nov;89(5 Pt 1):660–676. doi: 10.7326/0003-4819-89-5-660. [DOI] [PubMed] [Google Scholar]
  12. Ford S. E., Charrette E. J., Knight J., Pym J., Ford P. A possible role for antiphospholipid antibodies in acquired cardiac valve deformity. J Rheumatol. 1990 Nov;17(11):1499–1503. [PubMed] [Google Scholar]
  13. Galli M., Comfurius P., Maassen C., Hemker H. C., de Baets M. H., van Breda-Vriesman P. J., Barbui T., Zwaal R. F., Bevers E. M. Anticardiolipin antibodies (ACA) directed not to cardiolipin but to a plasma protein cofactor. Lancet. 1990 Jun 30;335(8705):1544–1547. doi: 10.1016/0140-6736(90)91374-j. [DOI] [PubMed] [Google Scholar]
  14. Hamsten A., Norberg R., Björkholm M., de Faire U., Holm G. Antibodies to cardiolipin in young survivors of myocardial infarction: an association with recurrent cardiovascular events. Lancet. 1986 Jan 18;1(8473):113–116. doi: 10.1016/s0140-6736(86)92258-0. [DOI] [PubMed] [Google Scholar]
  15. Khamashta M. A., Cervera R., Asherson R. A., Font J., Gil A., Coltart D. J., Vázquez J. J., Paré C., Ingelmo M., Oliver J. Association of antibodies against phospholipids with heart valve disease in systemic lupus erythematosus. Lancet. 1990 Jun 30;335(8705):1541–1544. doi: 10.1016/0140-6736(90)91373-i. [DOI] [PubMed] [Google Scholar]
  16. Khamashta M. A., Harris E. N., Gharavi A. E., Derue G., Gil A., Vázquez J. J., Hughes G. R. Immune mediated mechanism for thrombosis: antiphospholipid antibody binding to platelet membranes. Ann Rheum Dis. 1988 Oct;47(10):849–854. doi: 10.1136/ard.47.10.849. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Klemp P., Cooper R. C., Strauss F. J., Jordaan E. R., Przybojewski J. Z., Nel N. Anti-cardiolipin antibodies in ischaemic heart disease. Clin Exp Immunol. 1988 Nov;74(2):254–257. [PMC free article] [PubMed] [Google Scholar]
  18. Leung W. H., Wong K. L., Lau C. P., Wong C. K., Liu H. W. Association between antiphospholipid antibodies and cardiac abnormalities in patients with systemic lupus erythematosus. Am J Med. 1990 Oct;89(4):411–419. doi: 10.1007/BF01453668. [DOI] [PubMed] [Google Scholar]
  19. Mackworth-Young C. G., Loizou S., Walport M. J. Antiphospholipid antibodies and disease. Q J Med. 1989 Sep;72(269):767–777. [PubMed] [Google Scholar]
  20. Mackworth-Young C. Antiphospholipid antibodies: more than just a disease marker? Immunol Today. 1990 Feb;11(2):60–65. doi: 10.1016/0167-5699(90)90020-a. [DOI] [PubMed] [Google Scholar]
  21. Morton K. E., Gavaghan T. P., Krilis S. A., Daggard G. E., Baron D. W., Hickie J. B., Chesterman C. N. Coronary artery bypass graft failure--an autoimmune phenomenon? Lancet. 1986 Dec 13;2(8520):1353–1357. doi: 10.1016/s0140-6736(86)92004-0. [DOI] [PubMed] [Google Scholar]
  22. Nihoyannopoulos P., Gomez P. M., Joshi J., Loizou S., Walport M. J., Oakley C. M. Cardiac abnormalities in systemic lupus erythematosus. Association with raised anticardiolipin antibodies. Circulation. 1990 Aug;82(2):369–375. doi: 10.1161/01.cir.82.2.369. [DOI] [PubMed] [Google Scholar]
  23. Pengo V., Thiagarajan P., Shapiro S. S., Heine M. J. Immunological specificity and mechanism of action of IgG lupus anticoagulants. Blood. 1987 Jul;70(1):69–76. [PubMed] [Google Scholar]

Articles from British Heart Journal are provided here courtesy of BMJ Publishing Group

RESOURCES